SCHEMBL6707735

SCHEMBL6707735

O=C(Cc1cccc(F)c1)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3nnn[nH]3)[nH]c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 2/20 0.43
POLB P06746 2/20 0.38
RXFP1 Q9HBX9 2/20 0.38
MAPT P10636 2/20 0.38
TP53 P04637 1/20 0.38
KCNQ2 O43526 2/20 0.36
PLCG2 P16885 1/20 0.36
HDAC3 O15379 2/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC2 Q92769 2/20 0.35
NCOR2 Q9Y618 2/20 0.35
ROCK2 O75116 1/20 0.35
LMNA P02545 1/20 0.35
ABL1 P00519 1/20 0.35
SRC P12931 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NHERF1 O14745 2/20 0.35
GLS O94925 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6712041 0.94 LMNA (0.41) PARP14POLBKCNQ2PLCG2ROCK2
SCHEMBL6708944 0.93 PARP14 (0.39) PARP14POLBRXFP1MAPTTP53
SCHEMBL6708820 0.92 PARP14 (0.41) PARP14POLBTP53PLCG2LMNA
SCHEMBL6707755 0.91 PARP14 (0.43) PARP14POLBTP53PLCG2HDAC2
SCHEMBL6709118 0.91 PTK2B (0.40) PARP14POLBTP53KCNQ2PLCG2
SCHEMBL6708738 0.91 PARP14 (0.43) PARP14POLBRXFP1MAPTTP53
SCHEMBL6713088 0.90 PARP14 (0.45) PARP14RXFP1MAPTTP53KCNQ2
SCHEMBL6714087 0.90 NPY5R (0.42) PARP14POLBPLCG2HDAC3HDAC1
SCHEMBL6714191 0.90 PARP14 (0.45) PARP14POLBMAPTTP53KCNQ2
SCHEMBL6713933 0.89 RXFP1 (0.41) POLBRXFP1MAPTTP53KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PARP14 2597/4885POLB 626/4885RXFP1 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.